Analysts at Zacks Research raised their Q2 2025 earnings per share (EPS) estimates for Pediatrix Medical Group in a research ...

Zacks Research cut their FY2027 EPS estimates for PACCAR in a research note issued to investors on Monday, March 10th. Zacks Research analyst R. Singhi now expects that the company will post earnings ...

LDOS makes a strong case for investment in the aerospace-defense industry, given its solid earnings growth prospects, an impressive return on equity and rising backlog.

CNP is a solid pick in the utility space, given its growth prospects, strong ROE, better solvency, systematic investment plan and ability to raise shareholder value via regular dividends.

Hasbro (HAS) ended the recent trading session at $61.89, demonstrating a -1.68% swing from the preceding day's closing price. This change lagged the S&P 500's 0.49% gain on the day. Meanwhile, the Dow ...

The most recent trading session ended with Humacyte, Inc. (HUMA) standing at $2.99, reflecting a -0.33% shift from the previouse trading day's closing. The stock's change was less than the S&P 500's ...

Zacks Dividend Fund earns an Average Process ... Its equity investments include common stock, preferred stock, rights and warrants. The advisor intends to invest the fund's assets in the equity ...

Zacks All-Cap Core Fund earns an Average Process Pillar rating. The most important driver of the rating is the fund's impressive long-term risk-adjusted performance. This can be seen in its ten ...

The best free option is offered by ZACKS, FINVIZ has the best offering for swing traders, while buy-and-hold investors will find Stock Rover to be the best. TC2000 delivers the best interactive ...

Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds, and ETFs and how it impacts your life. This week ...